"10.1371_journal.pone.0051869","plos one","2012-12-20T00:00:00Z","Susanta Mondal; Jeffrey A Martinson; Supurna Ghosh; Richard Watson; Kalipada Pahan","Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, United States of America; Department of Immunology and Microbiology, Rush University Medical Center, Chicago, Illinois, United States of America; Revalesio Corporation, Tacoma, Washington, United States of America","Conceived and designed the experiments: SM KP. Performed the experiments: SM JAM SG RW. Analyzed the data: SM SG RW KP. Contributed reagents/materials/analysis tools: SG RW. Wrote the paper: SM KP.","Please note that Drs. RW and SG are full-time employees of Revalesio Corporation. This study has been funded by Revalesio Corporation. RNS60 is a drug candidate in development. However, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2012","12","Susanta Mondal","SM",5,TRUE,2,4,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
